Contineum Therapeutics, Inc. Class A Ownership | Who Owns Contineum Therapeutics, Inc. Class A?
Contineum Therapeutics, Inc. Class A Ownership Summary
Contineum Therapeutics, Inc. Class A is owned by 53.46% institutional investors, 1.61% insiders, and 44.93% retail investors. Johnson & johnson is the largest institutional shareholder, holding 7.64% of CTNM shares.
CTNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Contineum Therapeutics, Inc. Class A | 53.46% | 1.61% | 44.93% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Johnson & johnson | 1.98M | 7.64% | $8.13M |
| Suvretta capital management | 1.72M | 6.64% | $6.83M |
| Sectoral asset management | 800.79K | 3.09% | $3.18M |
| Perceptive advisors | 699.49K | 2.70% | $2.78M |
| Hhlr advisors | 669.34K | 2.58% | $2.66M |
| Samsara biocapital | 588.82K | 2.27% | $2.34M |
| Versant venture management | 542.63K | 2.10% | $2.15M |
| Point72 asset management | 388.64K | 1.50% | $1.54M |
| Saturn v capital management | 319.35K | 1.23% | $1.27M |
| Baker bros. advisors lp | 312.50K | 1.21% | $1.24M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant venture management | 542.63K | 2.62% | $2.15M |
| Johnson & johnson | 1.98M | 2.43% | $8.13M |
| Sectoral asset management | 800.79K | 2.10% | $3.18M |
| Saturn v capital management | 319.35K | 0.51% | $1.27M |
| Samsara biocapital | 588.82K | 0.48% | $2.34M |
| Suvretta capital management | 1.72M | 0.21% | $6.83M |
| Perceptive advisors | 699.49K | 0.10% | $2.78M |
| Adar1 capital management | 166.80K | 0.10% | $662.19K |
| Hhlr advisors | 669.34K | 0.09% | $2.66M |
| Casdin capital | 148.33K | 0.05% | $588.88K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 388.64K | 0.00% | 388.64K |
| Monaco asset management sam | 75.00K | 0.05% | 75.00K |
| Rbf capital | 40.00K | 0.01% | 40.00K |
| Y-intercept (hong kong) | 35.16K | 0.00% | 35.16K |
| Strategies wealth advisors | 50.00K | 0.02% | 25.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | 699.49K | 0.10% | -741.76K |
| Blackrock funding, inc. /de | 165.45K | - | -451.18K |
| Versant venture management | 542.63K | 2.62% | -375.54K |
| Stempoint capital lp | - | - | -265.83K |
| Saturn v capital management | 319.35K | 0.51% | -241.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 388.64K | 0.00% | 388.64K | $1.54M |
| Monaco asset management sam | 75.00K | 0.05% | 75.00K | $297.75K |
| Rbf capital | 40.00K | 0.01% | 40.00K | $158.80K |
| Y-intercept (hong kong) | 35.16K | 0.00% | 35.16K | $139.57K |
| Prelude capital management | 13.92K | 0.01% | 13.92K | $55.26K |
Sold Out
| Holder | Change |
|---|---|
| Golden state wealth management | -27.00 |
| Private wealth management group | -43.00 |
| Sterling capital management | -78.00 |
| Russell investments group | -318.00 |
| Amalgamated bank | -362.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 69 | 13.11% | 13,845,129 | 2.06% | 53 | 1.94% | 40 | 42.86% | 21 | 16.67% |
| Mar 31, 2025 | 62 | 5.08% | 15,117,518 | -3.45% | 58 | 0.89% | 27 | -30.77% | 18 | 100.00% |
| Dec 31, 2024 | 60 | 17.65% | 15,782,189 | 16.07% | 81 | 2.92% | 40 | 66.67% | 9 | -40.00% |
| Sep 30, 2024 | 51 | 4.08% | 13,597,553 | 4.46% | 52 | 2.06% | 24 | -51.02% | 15 | - |
| Jun 30, 2024 | 49 | - | 13,016,510 | - | 50 | - | 49 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 25, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $16.18K |
| Nov 18, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $99.73K |
| Nov 18, 2024 | Lorrain Daniel S. | Chief Scientific Officer | Sell | $1.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | - |
CTNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools